US CDC

The vaccine was approved in the US in 2019 to prevent smallpox and monkeypox in high-risk adults aged 18 years and older

FDA acting commissioner Janet Woodcock said it expected the pause to be a matter of days, and it was aimed at providing…

People who have had a severe allergic reaction to any ingredient in a COVID-19 vaccine should avoid the vaccine formulation…